PACLITAXEL

Advanced or residual ovarian cancer.

Adjuvant in node-positive breast cancer.

Locally advanced metastatic breast cancer.

Advanced non-small cell lung carcinoma.
AIDS-related Kaposi's sarcoma for which prior liposomal anthracycline therapy has failed.

More information

Molecule

PACLITAXEL

Pharmaceutical form

Injectable solution for intravenous use

Presentation

Caja con 1 frasco ampolla de 50 mL

Concentration

Cada frasco ampolla de 50 mL contiene: Paclitaxel 300 mg

Molecular structure

Sanitary registration

Guatemala

PF-48540

El Salvador

Honduras

Nicaragua

Costa Rica

Panama

201260

Ecuador

Dominican Republic

Other products

NEOBOL

CLOSTEBOL ACETATE, NEOMYCIN SULFATE

NEOBOL

CLOSTEBOL ACETATE, NEOMYCIN SULFATE

SEARCH

CEFTRIAXONE

SEARCH

CEFTRIAXONE